Erez vigodman wife and husband

By Cassandra Leger

Teva Pharmaceutical Industries Ltd announced in a January 9 press release that it had appointed Erez Vigodman as the company’s new President and CEO. Vigodman is set to begin his duties effective February 11, 2014.

Vigodman succeeds the interim President and CEO, Eyal Desheh, who will return to his previous position as Group EVP and Chief Financial Officer.

Erez Vigodman stated, “It is a great honor for me to be named President and CEO of Teva, a pioneer in the healthcare industry.

I am excited to work with the management team and Teva's employees to build on the great traditions of the company to solidify our global leadership and fully tap the company's great potential to deliver medicines and solutions to patients all over the world.

I understand the challenges facing Teva and I am confident that, together with the management team, we can address these challenges and deliver on our commitment to creating value for our shareholders by expan